DNA Link Begins Exporting COVID-19 Diagnostic Kits to Argentina and Other Countries
[Asia Economy Reporter Hyunseok Yoo] DNA Link announced on the 22nd that it will export its COVID-19 diagnostic kits to Argentina and other countries.
DNA Link shipped the initial batch for product registration and testing after signing a contract to supply a total of 7 million kits with Argentina's Alfarma SRL.
Alfarma SRL is a subsidiary of HLB Pharma Group SA, which was established in 2004. Headquartered in Argentina, it is a pharmaceutical company with branches in Brazil and Uruguay, producing medicines in collaboration with over 20 global pharmaceutical companies, including Aventis.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
A representative from DNA Link stated, "Currently, we are negotiating export contracts for COVID-19 diagnostic kits with more than 20 countries, including the United States, and have received requests for samples," adding, "We expect continuous orders for COVID-19 diagnostic kits in the future and anticipate achieving record-high performance after listing."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
